British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...
Older adults and newborn babies are among those most at risk, leading to serious cases of pneumonia, a high number of ...
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...
Bookings for millions of people to get their flu and COVID vaccines open today - find out if you're eligible to get the jabs, ...
RSV is a highly contagious virus that affects people of all ages, from infants to adults. Its symptoms often mimic those of influenza or COVID-19, making it hard to differentiate between these ...
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The ...
Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback